Cascade BioSciences Inc.
TSX: CSBXMid-cap oncology developer. Lead candidate CSB-204 in Phase II. Disclosure quality has deteriorated across the last two reporting cycles.
Insider trades
4 reported trades by directors and officers of Cascade BioSciences Inc..
Buy volume
$372,200
Sell volume
$216,700
Net flow
$155,500
| Insider | Action | Shares | Price | Value | Trade date | Reported |
|---|---|---|---|---|---|---|
Marcus Leung CFO | Sell | 22,000 | $9.85 | $216,700 | Jun 02, 2026 | 1mo ago |
Dr. Eleanor Whitcombe CEO | Buy | 18,000 | $9.40 | $169,200 | Apr 15, 2026 | 3mo ago |
Dr. Eleanor Whitcombe CEO | Buy | 25,000 | $8.12 | $203,000 | Feb 06, 2025 | 1y ago |
Marcus Leung CFO | Option Exercise | 40,000 | $3.50 | $140,000 | Jan 28, 2025 | 1y ago |